José Luís Blanco

9.9k total citations · 1 hit paper
91 papers, 2.7k citations indexed

About

José Luís Blanco is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, José Luís Blanco has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 41 papers in Virology and 35 papers in Epidemiology. Recurrent topics in José Luís Blanco's work include HIV/AIDS drug development and treatment (50 papers), HIV Research and Treatment (37 papers) and HIV/AIDS Research and Interventions (31 papers). José Luís Blanco is often cited by papers focused on HIV/AIDS drug development and treatment (50 papers), HIV Research and Treatment (37 papers) and HIV/AIDS Research and Interventions (31 papers). José Luís Blanco collaborates with scholars based in Spain, United Kingdom and United States. José Luís Blanco's co-authors include Estebán Martínez, Josep Mallolas, Ana Milinkovic, Montserrat Laguno, Elisa de Lazzari, Montserrat Loncà, María Ángeles Marcos, Agathe León, Amanda Mocroft and Miguel A García-Viejo and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

José Luís Blanco

81 papers receiving 2.6k citations

Hit Papers

Frequent detection of monkeypox virus DNA in saliva, seme... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022
    2022 248 citations Irene Fuertes, María Ángeles Marcos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José Luís Blanco Spain 25 1.7k 1.2k 974 650 625 91 2.7k
Anchalee Avihingsanon Thailand 29 1.7k 1.0× 852 0.7× 1.5k 1.5× 827 1.3× 827 1.3× 206 3.0k
Marc van der Valk Netherlands 39 2.6k 1.5× 1.9k 1.5× 1.6k 1.7× 1.3k 2.0× 1.0k 1.6× 212 4.6k
Catherine Godfrey United States 25 1.8k 1.1× 1.3k 1.1× 752 0.8× 651 1.0× 90 0.1× 80 2.8k
John R. Koethe United States 32 2.0k 1.2× 1.1k 0.9× 655 0.7× 2.4k 3.6× 96 0.2× 140 3.6k
Kenneth Rich United States 32 1.9k 1.1× 1.2k 1.0× 869 0.9× 881 1.4× 92 0.1× 80 3.3k
Frank A. Post United Kingdom 38 3.6k 2.2× 1.3k 1.1× 1.6k 1.7× 2.1k 3.3× 185 0.3× 185 4.8k
José L. Casado Spain 31 2.3k 1.4× 1.3k 1.1× 1.3k 1.3× 777 1.2× 478 0.8× 189 3.7k
Eva Wolf Germany 24 867 0.5× 480 0.4× 803 0.8× 297 0.5× 452 0.7× 108 2.3k
Karam Mounzer United States 30 1.4k 0.8× 1.4k 1.1× 974 1.0× 471 0.7× 416 0.7× 117 3.0k
Mallory D. Witt United States 37 2.7k 1.6× 1.6k 1.3× 1.7k 1.7× 1.7k 2.7× 469 0.8× 138 4.8k

Countries citing papers authored by José Luís Blanco

Since Specialization
Citations

This map shows the geographic impact of José Luís Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Luís Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Luís Blanco more than expected).

Fields of papers citing papers by José Luís Blanco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Luís Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Luís Blanco. The network helps show where José Luís Blanco may publish in the future.

Co-authorship network of co-authors of José Luís Blanco

This figure shows the co-authorship network connecting the top 25 collaborators of José Luís Blanco. A scholar is included among the top collaborators of José Luís Blanco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Luís Blanco. José Luís Blanco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vergara, Andrea, Iván Chivite, Ana González-Cordón, et al.. (2025). Detection of Neisseria gonorrhoeae and Chlamydia trachomatis by PCR in a sample pool (urine, rectum and pharynx) in asymptomatic patients at risk of sexually transmitted infections. Enfermedades Infecciosas y Microbiología Clínica. 43(7). 374–377.
3.
Laguno, Montserrat, Elisa de Lazzari, Alexy Inciarte, et al.. (2024). Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV. HIV Medicine. 25(12). 1308–1324. 1 indexed citations
4.
Llibre, Josep M., Féderico García, José Luís Blanco, et al.. (2024). Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain. HIV Medicine. 25(8). 946–957. 1 indexed citations
5.
Lazzari, Elisa de, Peré Domingo, Juan Tiraboschi, et al.. (2024). Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. Journal of Antimicrobial Chemotherapy. 79(5). 1133–1141. 1 indexed citations
6.
Martín-Iguacel, Raquel, Andreu Bruguera, Yesika Díaz, et al.. (2023). Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study. Microorganisms. 11(11). 2701–2701. 5 indexed citations
7.
Calle, Fernando, Miriam Estébanez, Marta Díaz‐Menéndez, et al.. (2023). Treatment and prevention of monkeypox. Enfermedades infecciosas y microbiologia clinica (English ed ). 41(10). 629–634. 9 indexed citations
8.
Calle, Fernando, Miriam Estébanez, Marta Díaz‐Menéndez, et al.. (2022). Tratamiento y prevención de la viruela del mono. Enfermedades Infecciosas y Microbiología Clínica. 41(10). 629–634. 2 indexed citations
9.
Blanco, José Luís, José Ramón Blanco, Julián Olalla, et al.. (2021). A prospective case-cohort study of covid-19 in persons with hiv: Covih-19 study. 29(1). 248–248.
10.
Fuertes, Irene, et al.. (2017). Emergencia de la sífilis: Estudio descriptivo de pacientes diagnosticados de sífilis en un hospital de tercer nivel entre 2011 y 2015. Medicina Clínica. 149(12). 536–539. 4 indexed citations
11.
Rojas, Jhon, José Luís Blanco, María Ángeles Marcos, et al.. (2016). Dolutegravir monotherapy in HIV-infected patients with sustained viral suppression. Journal of Antimicrobial Chemotherapy. 71(7). 1975–1981. 32 indexed citations
12.
Llibre, Josep M., Federico Pulido, Féderico García, et al.. (2015). Genetic barrier to resistance for dolutegravir.. PubMed. 17(1). 56–64. 82 indexed citations
13.
14.
Rhee, Soo‐Yon, José Luís Blanco, Tommy F. Liu, et al.. (2012). Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes. AIDS Research and Therapy. 9(1). 13–13. 2 indexed citations
15.
Laguno, Montserrat, María Larrousse, José Luís Blanco, et al.. (2008). Prevalence and Clinical Relevance of Occult Hepatitis B in the Fibrosis Progression and Antiviral Response to INF Therapy in HIV–HCV-Coinfected Patients. AIDS Research and Human Retroviruses. 24(4). 547–553. 12 indexed citations
16.
Larrousse, María, Montserrat Laguno, Marta Segarra, et al.. (2007). Noninvasive Diagnosis of Hepatic Fibrosis in HIV/HCV-Coinfected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(3). 304–311. 29 indexed citations
17.
Laguno, Montserrat, María Larrousse, Javier Murillas, et al.. (2006). Predictive Value of Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients Treated With an Interferon-Based Regimen Plus Ribavirin. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(2). 174–178. 18 indexed citations
18.
Suy, Anna, Estebán Martínez, Oriol Coll, et al.. (2005). Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 20(1). 59–66. 156 indexed citations
19.
Knobel, Hernando, José M. Miró, Beatriz Mahíllo, et al.. (2004). Failure of Cetirizine to Prevent Nevirapine-Associated Rash. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(2). 1276–1281. 14 indexed citations
20.
Martínez, Estebán, Amanda Mocroft, Miguel A García-Viejo, et al.. (2001). Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. The Lancet. 357(9256). 592–598. 347 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anchalee Avihingsanon Breakdown of academic impact, for papers by Marc van der Valk Breakdown of academic impact, for papers by Catherine Godfrey Breakdown of academic impact, for papers by John R. Koethe Breakdown of academic impact, for papers by Kenneth Rich Breakdown of academic impact, for papers by Frank A. Post Breakdown of academic impact, for papers by José L. Casado Breakdown of academic impact, for papers by Eva Wolf Breakdown of academic impact, for papers by Karam Mounzer Breakdown of academic impact, for papers by Mallory D. Witt
Rankless by CCL
2026